TY  - JOUR
AU  - Bolino, Alessandra
AU  - Piguet, Françoise
AU  - Alberizzi, Valeria
AU  - Pellegatta, Marta
AU  - Rivellini, Cristina
AU  - Noseda, Roberta
AU  - Brombin, Chiara
AU  - Nonis, Alessandro
AU  - D'Adamo, Patrizia
AU  - Taveggia, Carla
AU  - Previtali, Stefano C.
AU  - Guerrero Valero, Marta
PY  - 2016
DO  - 10.15252/emmm.201606349
UR  - https://hdl.handle.net/20.500.14352/133160
T2  - EMBO molecular medicine
AB  - Charcot-Marie-Tooth (CMT) neuropathies are highly heterogeneous disorders caused by mutations in more than 70 genes, with no available treatment. Thus, it is difficult to envisage a single suitable treatment for all pathogenetic mechanisms. Axonal...
LA  - eng
M2  - 1438
PB  - EMBO Press
KW  - Animal models
KW  - Charcot–Marie–Tooth neuropathies
KW  - Myelin
KW  - Neuregulin 1
KW  - Nicotinic acid
TI  - Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination
TY  - journal article
VL  - 8
ER  -